Zuriaga, María AFuster, Jose J.2023-12-152023-12-152023Clin Investig Arterioscler. 2023 Jan-Feb;35(1):35-41.http://hdl.handle.net/20.500.12105/16812Despite current standards of care, a considerable risk of atherosclerotic cardiovascular disease remains in both primary and secondary prevention. In this setting, clonal hematopoiesis driven by somatic mutations has recently emerged as a relatively common, potent and independent risk factor for atherosclerotic cardiovascular disease and other cardiovascular conditions. Experimental studies in mice suggest that mutations in TET2 and JAK2, which are among the most common in clonal hematopoiesis, increase inflammation and are causally connected to accelerated atherosclerosis development, which may explain the link between clonal hematopoiesis and increased cardiovascular risk. In this review, we provide an overview of our current understanding of this emerging cardiovascular risk factor.engAMhttp://creativecommons.org/licenses/by-nc-nd/4.0/Cardiovascular DiseasesAtherosclerosisAnimalsMiceClonal HematopoiesisHeart Disease Risk FactorsInflammationMutationAttribution-NonCommercial-NoDerivatives 4.0 Internacional348799803513510.1016/j.arteri.2021.09.0061578-1879Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosisopen access